Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Total 13F shares
-
23,578,976
-
Share change
-
+3,067,145
-
Total reported value
-
$634,746,122
-
Price per share
-
$26.92
-
Number of holders
-
51
-
Value change
-
+$86,851,459
-
Number of buys
-
26
-
Number of sells
-
33
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q1 2021
As of 31 Mar 2021,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,578,976 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, CANADA PENSION PLAN INVESTMENT BOARD, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., Casdin Capital, LLC, AMERIPRISE FINANCIAL INC, and FMR LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.